Based on the FIR, a special police team was formed, and the woman was rescued from Barmer and brought back home safely. (Photo | Express illustrations)
India

Police rescue Jharkhand woman who was sold for Rs 3 lakh by traffickers in Rajasthan

Police said the woman allegedly faced repeated torture at the hands of the family and also gave birth to a child during her captivity.

TNIE online desk

The Jharkhand Police have rescued a 22-year-old woman from Simdega, who was allegedly trafficked and sold for Rs 3 lakh in Rajasthan, officials said on Tuesday.

The woman was taken to Delhi in 2023 from a village in the Kurdeg police station area in Simdega district by a man from a neighbouring village who had promised her a job, they said.

DSP (Headquarters) Ranvir Singh said the woman was initially employed as a domestic help through a placement agency in Delhi.

However, she fled the house after a few days.

"While she was wandering near Anand Vihar bus stand in Delhi, a couple from Meerut took her with them.

The couple later sold her for Rs 3 lakh to a family in Barmer near the India-Pakistan border," Singh told PTI.

Police said the woman allegedly faced repeated torture at the hands of the family and also gave birth to a child during her captivity.

The victim later managed to contact her mother and narrated her ordeal.

The woman's parents then lodged an FIR at the Anti-Human Trafficking Unit (AHTU) police station in Simdega on May 20.

Based on the FIR, a special police team was formed, and the woman was rescued from Barmer and brought back home safely, the DSP said.

(With inputs from PTI)

Why the additional declaration linked to Form 6 is facing a legal challenge

SP-Congress alliance faces fresh strain as Akhilesh skips INDIA bloc meet over UP seat-sharing talks

Rahul Gandhi tells CWC to continue 'resistance' against 'match-fixing' of polls through EVM, voters list

Assam Rifles jawan killed in militant attack in Arunachal; security forces intensify ops to arrest killers

SC slams medicine pricing, calls cancer drug’s 10-fold MRP markup ‘carnage’